News, events and chat from Sheffield and South Yorkshire.
‘If there’s a gold rush, sell shovels’: The dodgy dealers behind Sheffield’s peptide boom – sheffieldtribune.co.uk
An investigation by the Sheffield Tribune has exposed an underground market for unlicensed "peptide" drugs in the city, with unapproved substances such as Retatrutide being injected by residents ranging from menopausal women to students seeking weight loss or performance gains. The trade, described by one gym owner as "a massive, massive industry" that has overtaken steroids, is largely unregulated, with sellers operating via Facebook Marketplace and WhatsApp and offering little safety oversight — prompting comparisons to "gold rush" opportunists selling shovels rather than striking gold themselves. The UK's medicines regulator has warned that "rogue sellers" are prioritising profit over consumer safety.
The report features Sarah, a 48-year-old cleaner who lost two stone in four months on Retatrutide but suffered six weeks of nausea, headaches and lethargy before continuing the treatment regardless. It also details an unlicensed Crookesmoor dealer known as "Dr Chow," who runs a website-less operation selling 88 different products priced from £5 to several hundred pounds, including a £210 humanin product. By contrast, legitimate NHS-adjacent alternatives such as Mounjaro cost between £125 and £320 a month. In July 2026 the Medicines and Healthcare products Regulatory Agency (MHRA), whose enforcement head Andy Morling gave comment for the piece, issued a public warning about the health risks of buying such peptides outside regulated channels.
In short
- Sheffield has an unregulated black market for injectable weight-loss/performance peptides
- Buyers risk severe side effects; one seller offers 88 unlicensed products
- MHRA has issued a public warning over "rogue sellers" prioritising profit
Explained simply
Peptides are short chains of amino acids, and some are used in medicines. Retatrutide is an experimental weight-loss drug that is not licensed for general use in the UK. Unlicensed products sold online or through private messages may not have been checked for their quality, contents or safety.
The Sheffield market described in the report involves sellers and buyers, including people seeking weight loss or changes in athletic performance. Some sellers offer many products through social media and messaging apps, while buyers may have little access to reliable information or medical supervision. The MHRA regulates medicines in the UK and has warned about buying these products outside regulated channels.
The issue matters because an unapproved product can carry health risks, and its contents or strength may be uncertain. Licensed treatments, including some available through NHS-linked services, are supplied under different regulatory and clinical safeguards.